Serum concentrations of cefuroxime after continuous infusion in coronary bypass graft patients

Annals of Pharmacotherapy

Volumn 35, Issue 4, 2001, Pages 409-413

  Pass, Steven E ^a   Miyagawa, Clyde I ^b   Healy, Daniel P ^c   Ivey, Tom D ^d  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b Ortho McNeil Pharmaceutical   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d Cardiac Surgery   (United States)

Author keywords

Cefuroxime; Continuous infusion; Coronary artery bypass graft; Surgical prophylaxis

Indexed keywords

ANTIBIOTIC AGENT; CEFUROXIME;

ADULT; ARTICLE; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS GRAFT; DRUG BLOOD LEVEL; DRUG COST; HUMAN; INCIDENCE; INFECTION PREVENTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STEADY STATE; STERNUM; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; CEFUROXIME; CEPHALOSPORINS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURGICAL WOUND INFECTION;

EID: 0035094994     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10174     Document Type: Article

References (14)

1. Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1030 patients
2. CDC definitions of nosocomial surgical site infections, 1992: A modification of CDC definitions of surgical wound infections
3. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care
4. Continuous infusion of β-lactam antibiotics
5. Beta-lactam antibiotics: Is continuous infusion the preferred method of administration?
6. Prediction of creatinine clearance from serum creatinine
7. Cefuroxime by continuous infusion: A new standard of care?
8. A high performance liquid chromatography system for the simultaneous assay of some antibiotics commonly found in combination in clinical samples
9. Is continuous infusion of β-lactam antibiotics worthwhile? Efficacy and pharmacokinetic considerations
10. Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections
11. Serum bactericidal activity of ceftazidime: Continuous infusion versus intermittent injections
12. Cephalosporins
13. Drug allergy